Skip to Main Content

Paper Details

Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome.
Lancet Diabetes Endocrinol
26
2019
Author NameAffiliation
Mark S AndersonUniversity of California at San Francisco
Kevan C HeroldYale University
  • 1 - 2

Datasets

Release 1.2